J&J explores bid for Intra-Cellular Therapies, Bloomberg News reports

SHARE NOW

(Reuters) – Johnson & Johnson is exploring a bid to acquire Intra-Cellular Therapies Inc, a biopharmaceutical company, Bloomberg News reported on Sunday citing people familiar with the matter.

(Reporting by Angela Christy in Bengaluru; Editing by Sandra Maler)

Brought to you by www.srnnews.com

Submit a Comment